Searching News Database: Chronic Obstructive Pulmonary Disease
HSMN NewsFeed - 2 Feb 2023
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
HSMN NewsFeed - 13 Jul 2022
SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study
SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study
HSMN NewsFeed - 3 Feb 2022
Third Pole Therapeutics Closes $25M Financing - eNOfit(TM) Wearable Device Now Ready for Clinical Trials
Third Pole Therapeutics Closes $25M Financing - eNOfit(TM) Wearable Device Now Ready for Clinical Trials
HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
HSMN NewsFeed - 22 Jun 2021
Valeo Pharma Announces Commercial Launch of Enerzair(R) Breezhaler(R) and Atectura(R) Breezhaler(R)
Valeo Pharma Announces Commercial Launch of Enerzair(R) Breezhaler(R) and Atectura(R) Breezhaler(R)
HSMN NewsFeed - 15 Apr 2021
Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
HSMN NewsFeed - 18 Jan 2021
New Treatment for Severe Emphysema Now Covered Under Highmark Blue Cross Blue Shield
New Treatment for Severe Emphysema Now Covered Under Highmark Blue Cross Blue Shield
HSMN NewsFeed - 22 Oct 2020
CSA Medical Announces First Procedure in the SPRAY-CB Pivotal Trial for the Treatment of Chronic Bronchitis
CSA Medical Announces First Procedure in the SPRAY-CB Pivotal Trial for the Treatment of Chronic Bronchitis
HSMN NewsFeed - 17 Aug 2020
Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent(R) Diskus(R)
Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent(R) Diskus(R)
HSMN NewsFeed - 19 Jun 2020
Dupixent(R) (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
Dupixent(R) (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
HSMN NewsFeed - 4 Sep 2019
Gala Therapeutics Receives CE Mark for its Minimally Invasive RheOx(TM) System for Chronic Bronchitis
Gala Therapeutics Receives CE Mark for its Minimally Invasive RheOx(TM) System for Chronic Bronchitis
HSMN NewsFeed - 11 Feb 2019
Nuvaira Announces a $79 Million Financing Round to Pursue Groundbreaking Treatment of COPD
Nuvaira Announces a $79 Million Financing Round to Pursue Groundbreaking Treatment of COPD
HSMN NewsFeed - 5 Dec 2018
Olympus Spiration(R) Valve System Is FDA Approved for the Endobronchial Treatment of Emphysema
Olympus Spiration(R) Valve System Is FDA Approved for the Endobronchial Treatment of Emphysema
HSMN NewsFeed - 30 Apr 2018
Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough
Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough
HSMN NewsFeed - 23 Oct 2017
United Therapeutics Announces FDA Approval of Third Generation Nebulizer for the Tyvaso(R) Inhalation System
United Therapeutics Announces FDA Approval of Third Generation Nebulizer for the Tyvaso(R) Inhalation System
HSMN NewsFeed - 17 May 2017
Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel
Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel
HSMN NewsFeed - 12 Jan 2017
ResMed's myAir(TM) Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea
ResMed's myAir(TM) Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea
HSMN NewsFeed - 5 Oct 2016
Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor
Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor
HSMN NewsFeed - 8 Aug 2016
Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer
Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer
HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
HSMN NewsFeed - 29 Feb 2016
Genentech Provides Update On Two Identical Phase III Studies Of Lebrikizumab In People With Severe Asthma
Genentech Provides Update On Two Identical Phase III Studies Of Lebrikizumab In People With Severe Asthma
HSMN NewsFeed - 23 Sep 2015
XENiOS(R) Receives Cash Infusion from Existing Investors to Expand Commercial Operations in US and Europe
XENiOS(R) Receives Cash Infusion from Existing Investors to Expand Commercial Operations in US and Europe
HSMN NewsFeed - 26 Sep 2014
Biota Pharmaceuticals Announces Changes to Management and Board of Directors
Biota Pharmaceuticals Announces Changes to Management and Board of Directors
HSMN NewsFeed - 26 Aug 2014
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
HSMN NewsFeed - 29 May 2014
Masimo Announces CE Mark of iSpO2(TM) Rx Pulse Oximeter for Mobile Devices
Masimo Announces CE Mark of iSpO2(TM) Rx Pulse Oximeter for Mobile Devices
HSMN NewsFeed - 29 Apr 2014
Teva Receives European Marketing Authorization for DuoResp Spiromax(R) for the Treatment of Asthma and COPD
Teva Receives European Marketing Authorization for DuoResp Spiromax(R) for the Treatment of Asthma and COPD
HSMN NewsFeed - 30 Dec 2013
Electromed, Inc. Receives FDA Market Clearance for the SmartVest(R) SQL(TM)
Electromed, Inc. Receives FDA Market Clearance for the SmartVest(R) SQL(TM)
HSMN NewsFeed - 18 Dec 2013
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
HSMN NewsFeed - 20 Sep 2013
RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
HSMN NewsFeed - 26 Feb 2013
Cytori Appoints Dr. Steven Kesten as Executive Vice President and Chief Medical Officer
Cytori Appoints Dr. Steven Kesten as Executive Vice President and Chief Medical Officer
HSMN NewsFeed - 25 Feb 2013
First U.S. Patients Treated in PneumRx RENEW Pivotal Study for Treatment of Severe Emphysema
First U.S. Patients Treated in PneumRx RENEW Pivotal Study for Treatment of Severe Emphysema
HSMN NewsFeed - 26 Oct 2012
NICE Approves Pharmaxis' Bronchitol(R) As An Important New Treatment Option For Cystic Fibrosis Patients
NICE Approves Pharmaxis' Bronchitol(R) As An Important New Treatment Option For Cystic Fibrosis Patients
HSMN NewsFeed - 28 Sep 2012
Seebri(R) Inhalation Capsules Receive MHLW Approval as Once-daily Maintenance Treatment for COPD in Japan
Seebri(R) Inhalation Capsules Receive MHLW Approval as Once-daily Maintenance Treatment for COPD in Japan
HSMN NewsFeed - 5 Sep 2012
Sunovion Pharmaceuticals Inc. Completes Acquisition of Elevation Pharmaceuticals, Inc.
Sunovion Pharmaceuticals Inc. Completes Acquisition of Elevation Pharmaceuticals, Inc.
HSMN NewsFeed - 13 Jul 2012
GSK and Theravance Announce Regulatory Submissions for FF/VI in the US and Europe
GSK and Theravance Announce Regulatory Submissions for FF/VI in the US and Europe
HSMN NewsFeed - 2 Jun 2011
GSK and Theravance Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD
GSK and Theravance Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD
HSMN NewsFeed - 27 Apr 2011
Deep Breeze Introduces Breeze@home(TM) -- A New Telemonitoring Device to Improve COPD Assessment
Deep Breeze Introduces Breeze@home(TM) -- A New Telemonitoring Device to Improve COPD Assessment
HSMN NewsFeed - 7 Mar 2011
Breathe Technologies Receives FDA Clearance for Home Use of Portable Ventilator
Breathe Technologies Receives FDA Clearance for Home Use of Portable Ventilator
HSMN NewsFeed - 24 Feb 2011
Pearl Therapeutics Appoints Charles (Chuck) Bramlage President and Chief Executive Officer
Pearl Therapeutics Appoints Charles (Chuck) Bramlage President and Chief Executive Officer
HSMN NewsFeed - 24 Aug 2010
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA
HSMN NewsFeed - 1 Jun 2010
Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus
Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus
HSMN NewsFeed - 26 Apr 2010
Nycomed and Merck & Co., Inc., Announce Commercialization Agreements For Daxas(R) in Europe and Canada
Nycomed and Merck & Co., Inc., Announce Commercialization Agreements For Daxas(R) in Europe and Canada
HSMN NewsFeed - 7 Apr 2010
Entest BioMedical, Inc. Announces the Addition of New Chief Financial Officer to Management Team
Entest BioMedical, Inc. Announces the Addition of New Chief Financial Officer to Management Team
HSMN NewsFeed - 23 Feb 2010
Environmental Tectonics Corporation Announces Additional Baramed Monoplace Hyperbaric Chamber Sales
Environmental Tectonics Corporation Announces Additional Baramed Monoplace Hyperbaric Chamber Sales
HSMN NewsFeed - 17 Dec 2009
FDA Approves SPIRIVA(R) HandiHaler(R) for the Reduction of COPD Exacerbations
FDA Approves SPIRIVA(R) HandiHaler(R) for the Reduction of COPD Exacerbations
HSMN NewsFeed - 13 Aug 2009
Covidien Announces Iowa Health System's Conversion to the Nellcor OxiMax Pulse Oximetry System
Covidien Announces Iowa Health System's Conversion to the Nellcor OxiMax Pulse Oximetry System
HSMN NewsFeed - 8 Jun 2009
Medical Acoustics Files Application with FDA for 510(k) Clearance of Therapeutic Lung Flute
Medical Acoustics Files Application with FDA for 510(k) Clearance of Therapeutic Lung Flute
HSMN NewsFeed - 27 May 2009
Covidien Launches Alarm Management System for the Nellcor(TM) OxiMax(TM) N-600x(TM) Pulse Oximeter
Covidien Launches Alarm Management System for the Nellcor(TM) OxiMax(TM) N-600x(TM) Pulse Oximeter
HSMN NewsFeed - 21 May 2009
Budesonide/Formoterol Plus Tiotropium Improves the Quality of Life of Patients With Severe COPD
Budesonide/Formoterol Plus Tiotropium Improves the Quality of Life of Patients With Severe COPD
HSMN NewsFeed - 16 Apr 2009
Covidien Launches Alarm Management System for the Nellcor OxiMax N-600x Pulse Oximeter
Covidien Launches Alarm Management System for the Nellcor OxiMax N-600x Pulse Oximeter
HSMN NewsFeed - 1 Oct 2008
Cardica's Anastomosis Systems Enable 'Total Connector' Beating Heart Cardiac Bypass Procedures
Cardica's Anastomosis Systems Enable 'Total Connector' Beating Heart Cardiac Bypass Procedures
HSMN NewsFeed - 18 Sep 2008
Enbrel(R) Shown to Deliver Long-Lasting Improvements in Psoriasis Patients' Quality of Life
Enbrel(R) Shown to Deliver Long-Lasting Improvements in Psoriasis Patients' Quality of Life
HSMN NewsFeed - 14 Aug 2008
TOPIGEN Pharmaceuticals Appoints Mark Parry-Billings, Ph.D., as Chief Executive Officer
TOPIGEN Pharmaceuticals Appoints Mark Parry-Billings, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 13 Jun 2008
NicOx announces blood pressure analysis from 301 phase 3 study for naproxcinod at EULAR
NicOx announces blood pressure analysis from 301 phase 3 study for naproxcinod at EULAR
HSMN NewsFeed - 21 May 2008
Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50
Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50
HSMN NewsFeed - 30 Apr 2008
FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
HSMN NewsFeed - 26 Mar 2008
Breathe Technologies, Inc. Closes on $15 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers
Breathe Technologies, Inc. Closes on $15 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers
HSMN NewsFeed - 21 Feb 2008
Talecris Biotherapeutics Celebrates 20th Anniversary of Launch of Prolastin(R)
Talecris Biotherapeutics Celebrates 20th Anniversary of Launch of Prolastin(R)
HSMN NewsFeed - 28 Jan 2008
Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
HSMN NewsFeed - 16 Jan 2008
Teva Specialty Pharmaceuticals and UCB Announce U.S. Respiratory Collaboration Agreement
Teva Specialty Pharmaceuticals and UCB Announce U.S. Respiratory Collaboration Agreement
HSMN NewsFeed - 23 Nov 2007
Orexo Completes the Acquisition of Biolipox, Appoints New CEO and Publishes a Prospectus
Orexo Completes the Acquisition of Biolipox, Appoints New CEO and Publishes a Prospectus
HSMN NewsFeed - 14 Nov 2007
FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
HSMN NewsFeed - 6 Nov 2007
REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide
REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide
HSMN NewsFeed - 22 Oct 2007
Deep Breeze Ltd. Launches Unique Non-Invasive, Radiation-Free Pulmonary Imaging System in the U.S.
Deep Breeze Ltd. Launches Unique Non-Invasive, Radiation-Free Pulmonary Imaging System in the U.S.
HSMN NewsFeed - 15 Oct 2007
Clinical Studies Show REMICADE Reduces Incidence of Bowel Surgeries in Ulcerative Colitis Patients
Clinical Studies Show REMICADE Reduces Incidence of Bowel Surgeries in Ulcerative Colitis Patients
HSMN NewsFeed - 25 Sep 2007
Critical Therapeutics Highlights Near-Term Milestones to Drive Commercial Success and Clinical Development
Critical Therapeutics Highlights Near-Term Milestones to Drive Commercial Success and Clinical Development
HSMN NewsFeed - 18 Sep 2007
New Data Support Long-Term Efficacy and Safety in Patients Who Took Exubera for Eight Years
New Data Support Long-Term Efficacy and Safety in Patients Who Took Exubera for Eight Years
HSMN NewsFeed - 18 Jul 2007
FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
HSMN NewsFeed - 7 Jun 2007
Remicade(R) Receives EU Approval as First and Only Biologic Treatment for Pediatric Crohn's Disease
Remicade(R) Receives EU Approval as First and Only Biologic Treatment for Pediatric Crohn's Disease
HSMN NewsFeed - 25 Apr 2007
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
HSMN NewsFeed - 13 Apr 2007
First Patient Enrolled in Phase 2 'PLASMA' Trial With A-002 for Patients With Coronary Atherosclerosis
First Patient Enrolled in Phase 2 'PLASMA' Trial With A-002 for Patients With Coronary Atherosclerosis
HSMN NewsFeed - 10 Apr 2007
TOPIGEN Expands Executive Team With Senior Business Development and Pharmaceutical Development Appointments
TOPIGEN Expands Executive Team With Senior Business Development and Pharmaceutical Development Appointments
HSMN NewsFeed - 14 Mar 2007
Critical Therapeutics and DEY, L.P. Enter into Co-Promotion Agreement for Respiratory Care Products
Critical Therapeutics and DEY, L.P. Enter into Co-Promotion Agreement for Respiratory Care Products
HSMN NewsFeed - 28 Feb 2007
EPIX Pharmaceuticals Files Formal Appeal for Vasovist(TM) with the Center for Drug Evaluation and Research
EPIX Pharmaceuticals Files Formal Appeal for Vasovist(TM) with the Center for Drug Evaluation and Research
HSMN NewsFeed - 7 Feb 2007
Dr. David D. Waters Joins Anthera Pharmaceuticals as Cardiovascular Research Fellow
Dr. David D. Waters Joins Anthera Pharmaceuticals as Cardiovascular Research Fellow
HSMN NewsFeed - 2 Feb 2007
New Analyses Reinforce Efficacy of REMICADE(R) in Treatment of Severe Psoriasis
New Analyses Reinforce Efficacy of REMICADE(R) in Treatment of Severe Psoriasis
HSMN NewsFeed - 2 Feb 2007
REMICADE(R) Therapy Shown to Improve Productivity in Patients Treated for Chronic Plaque Psoriasis
REMICADE(R) Therapy Shown to Improve Productivity in Patients Treated for Chronic Plaque Psoriasis
HSMN NewsFeed - 8 Jan 2007
VIASYS Receives FDA Approval to Market Its PulmoLife(TM) Spirometry Screener
VIASYS Receives FDA Approval to Market Its PulmoLife(TM) Spirometry Screener
HSMN NewsFeed - 29 Dec 2006
Savient Pharmaceuticals Announces Launch of Authorized Generic of Oxandrin(R) with Watson Pharmaceuticals
Savient Pharmaceuticals Announces Launch of Authorized Generic of Oxandrin(R) with Watson Pharmaceuticals
HSMN NewsFeed - 14 Dec 2006
EPIX Pharmaceuticals to File Appeal with the Center for Drug Evaluation and Research for Vasovist(TM)
EPIX Pharmaceuticals to File Appeal with the Center for Drug Evaluation and Research for Vasovist(TM)
HSMN NewsFeed - 6 Nov 2006
Pharmacopeia Announces the Appointment of Vice President, Clinical and Regulatory Affairs
Pharmacopeia Announces the Appointment of Vice President, Clinical and Regulatory Affairs
HSMN NewsFeed - 23 Oct 2006
Data Show Treatment With Remicade(R) Reduced Hospitalizations for Ulcerative Colitis Patients By Half
Data Show Treatment With Remicade(R) Reduced Hospitalizations for Ulcerative Colitis Patients By Half
HSMN NewsFeed - 6 Sep 2006
Dynavax Establishes Collaboration for TLR-9 Agonists for Asthma and COPD With AstraZeneca
Dynavax Establishes Collaboration for TLR-9 Agonists for Asthma and COPD With AstraZeneca
HSMN NewsFeed - 20 Jul 2006
GSK Announces U.S. Government Purchase of Relenza(R) for State Stockpiles
GSK Announces U.S. Government Purchase of Relenza(R) for State Stockpiles
HSMN NewsFeed - 30 Jun 2006
EPIX Pharmaceuticals Files Appeal with FDA Regarding Vasovist(TM) Approvable Letters
EPIX Pharmaceuticals Files Appeal with FDA Regarding Vasovist(TM) Approvable Letters
Additional items found! 136
Members Archive contains
136 additional stories matching:
Chronic Obstructive Pulmonary Disease
(Password required)
Chronic Obstructive Pulmonary Disease
(Password required)